Week In Review: Chi-Next Exchange Rejects BGI's $260 Million IPO Application

Shenzhen's Chi-Next Exchange rejected the latest IPO proposal from BGI, China's giant genomic sequencing company. The problem? Insufficient documentation, according to a report from ChinaMoneyNetwork.com.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.